MONDAY, MAY 23, 2005

COURSE 33: PSYCHIATRIC CONSULTATION IN LONG-TERM CARE

Director: George T. Grossberg, M.D. Faculty: Judith H.W. Crossett, M.D., Abhilash K. Desai, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) learn the epidemiology of mental disorders in long-term-care residents and process of consultation, including reimbursement issues and OBRA regulations, and (2) learn various etiologies of behavioral disturbances and management using appropriate pharmacologic and nonpharmacologic interventions. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 23, 8-12; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 25

COURSE 34: ENGAGING RESISTANT AND DIFFICULT-TO-TREAT PATIENTS

Director: David Mee-Lee, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) identify ways for clinicians to better deal with resistance and hostility; (2) demonstrate skills to assess readiness; and (3) apply strategies to engage patients. Course Level: This is a basic course. No prior knowledge or experience is required. This is a repeat of a course given last year. Mon., May 23, 8-12; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 25

COURSE 35: CURRENT CPT CODING AND DOCUMENTATION REQUIREMENTS

Co-Directors: Chester W. Schmidt Jr., M.D., Tracy R. Gordy, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) understand the use of psychiatric evaluation codes, therapeutic procedure codes, and evaluation and management codes and (2) document the provision of services denoted by the above sets of codes. Course Level: This is a basic course. No previous experience or knowledge is required. Participants are encouraged to obtain the most recent published CPT manual and read the guideline section for “Evaluation and Management Codes,” the section “Evaluation and Management Codes,” and the section “Psychiatric Evaluation and Therapeutic Procedures.” This is a repeat of a course given last year. Mon., May 23, 8-12; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 50

COURSE 36: TEACHING PSYCHIATRY? LET HOLLYWOOD HELP!

Director: Steven E. Hyler, M.D. Faculty: Carol A. Bernstein, M.D., Michael B. First, M.D., Jeremy R. Butler, M.D. Educational Objective: At the conclusion of this course, the participant should be able to enhance his or her effectiveness in teaching medical students and residents through the use of selected commercial film depictions of psychopathology, diagnosis, and therapy. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 23, 8-12; Atlanta Hilton; fee: advance $100, on site $130; spaces available: 25

COURSE 37: DISASTER PSYCHIATRY: TERRORISM, TRAUMA, AND THINGS TO DO

Director: Joseph C. Napoli, M.D. Faculty: Michael Blumenfield, M.D., V. Alex Kehayan, Ed.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) summarize the psychiatrist's role in outreach disaster response; (2) arrange to participate in disaster responses; (3) explain the psychiatric aspects of responding to disaster; (4) employ risk-communication principles; (5) appraise the pitfalls and benefits of working with the media; and (6) and perform psychological first aid. Course Level: This is an intermediate course. The basic APA CME disaster psychiatry course, “Psychiatric Interventions in Disasters and Public Health Emergencies: Theory to Practice,” is recommended. This is a repeat of a course given last year. Mon., May 23, 8-12; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 50. A similar course on this topic will be offered on Sat., May 21, 1-5. See Course 9 for details.

COURSE 38: FAMILIES COPING WITH MEDICAL ILLNESS: AN INTEGRATIVE TREATMENT APPROACH

Director: John S. Rolland, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) understand comprehensive resilience-based family systems model for assessment and clinical intervention with individuals, couples, and families facing chronic and life-threatening physical disorders; (2) recognize the significance of life cycles and multigenerational patterns in illness; (3) link family beliefs related to illness; (4) understand factors that impede or facilitate the patient, family, and professional relationship; (5) identify key clinical issues for couples and families; and (6) suggest brief interventions and other timely and cost-effective applications of the model. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 23, 8-12; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 50

COURSE 39: THE PSYCHIATRIST AS EXPERT WITNESS

Director: Phillip J. Resnick, M.D. Educational Objective: At the conclusion of this course, the participant should be able to give more effective expert-witness testimony in civil and criminal trials. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 23, 8-12; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 100

COURSE 40: PSYCHIATRIC GENOMICS: APPLICATIONS FOR CLINICAL PRACTICE

Director: David A. Mrazek, M.D. Faculty: John L. Black, M.D., Brett A. Koplin, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) review basic medical genomics including the identification of new genes with disease relevance; (2) describe genetic markers such as RFLPs and SNPs; (3) identify new ways of characterization of subcategories of disease; (4) learn potential new ways to diagnose and identify risk factors; (5) learn about improved therapeutic interventions through pharmacogenomics; (6) explain two uses of microarray technology in psychogenomic research; (7) interpret genetic test results and communicate the findings to patients and families; (8) learn how to use publicly available bioinformatics databases to search for information about genetic influences on psychiatric illness; and (9) understand the relevance and utility of genetic testing to optimize outcomes in clinical psychiatric practice. Course Level: This is a basic course. Participants should have some background in basic biology, but this course is designed to provide participants with a basic review of molecular genetics. This is a revision of a course given last year. Mon., May 23, 8-12; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 100

COURSE 41: OFFICE-BASED BUPRENORPHINE TREATMENT OF OPIOID-DEPENDENT PATIENTS

Co-Directors: Gerardo Gonzalez, M.D., Eric C. Strain, M.D. Faculty: Laura F. McNicholas, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) identify the clinically relevant pharmacological characteristics of buprenorphine; (2) describe the resources needed to set up office-based treatment with buprenorphine for patients with opioid dependence; and (3) list at least five factors to consider in determining if the patient is an appropriate candidate for office-based treatment with buprenorphine. Course Level: This is a basic course. No previous experience or knowledge required. This is a repeat of a course given last year. Mon., May 23, 8-5; Hilton Atlanta; fee: advance $200, on site $260; spaces available: 100

COURSE 42: A PSYCHODYNAMIC APPROACH TO TREATMENT-REFRACTORY MOOD DISORDERS

Director: Eric M. Plakun, M.D. Faculty: David L. Mintz, M.D., Edward R. Shapiro, M.D. Educational Objective: At the conclusion of this course, the participant should be able to enumerate and utilize psychodynamic principles to improve outcomes in work with patients with treatment-refractory mood disorders comorbid with other disorders, including prominent Axis II pathology. Training directors will be better able to teach psychodynamic therapy to residents. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 23, 9-4; Hilton Atlanta; fee: advance $160, on site $185; spaces available: 75

COURSE 43: PERSONNEL MANAGEMENT FOR CLINICIAN-ADMINISTRATORS

Director: Stephen M. Soltys, M.D. Faculty: Joseph J. Parks III, M.D., Kay Titchenal. Educational Objective: At the conclusion of this course, the participant should be able to deal with personnel situations that commonly confront a clinician-administrator and be familiar with related legal issues. Course Level: This is a basic course. No previous experience or knowledge is required. Mon., May 23, 9-4; Hilton Atlanta; fee: advance $160, on site $185; spaces available: 50

COURSE 44: MONEY MATTERS I: USING THEORY IN CLINICAL PRACTICE

Director: Cecilia M. Mikalac, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) recognize the different values of money in discussion with patients; (2) understand the influence of money on payment and collection behavior; (3) understand influence of poverty, wealth, status, race, and privilege on payment; (4) cite a range of payment guidelines and methods of handling nonpayment; and (5) discuss money issues with patients and colleagues with less anxiety. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 23, 9-4; Hilton Atlanta; fee: advance $160, on site $185; spaces available: 25. An advanced course on this topic will be offered on Tue., May 24, 9-4. See Course 67 for details.

COURSE 45: ADVANCED HYPNOSIS: APPLICATIONS IN PSYCHIATRY

Director: Jose R. Maldonado, M.D. Faculty: David Spiegel, M.D., Matthew May, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) assess hypnotizability in the clinical setting; (2) develop psychotherapeutic strategies employing hypnosis; and (3) acquire specific treatment strategies for dealing with anxiety, dissociative, and somatoform disorders. Course Level: This is an intermediate course. Prior training or experience with hypnosis and a basic knowledge in hypnosis will be presumed. This is a revision of a course given last year. Mon., May 23, 9-4; Hilton Atlanta; fee: advance $160, on site $185; spaces available: 50. A basic course on this topic will be offered on Sun., May 22, 9-4. See Course 25 for details.

COURSE 46: TREATING THE SELF AND INTERPERSONAL PROBLEMS OF PERSONALITY DISORDER

Director: John Livesley, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) understand a model of self and interpersonal pathology based on information-processing mechanisms; (2) describe a framework for treating personality disorder; (3) use multiple interventions to change maladaptive schemata and relationship patterns; and (4) use strategies to facilitate the development of a more adaptive self system. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 23, 9-4; Hilton Atlanta; fee: advance $160, on site $185; spaces available: 75. Similar courses on this topic will be offered on Sun., May 22, 8-12 and 9-4. See Courses 19 and 23 for details.

COURSE 47: ADVANCES IN NEUROPSYCHIATRY

Director: C. Edward Coffey, M.D. Faculty: Mark S. George, M.D., Michael R. Trimble, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) relate brain anatomy and chemistry to human behavior; (2) understand the role of brain imaging in the assessment of neuropsychiatric illness; and (3) diagnose and effectively manage disorders of behavior secondary to brain disease. Course Level: This is a basic course. No experience or knowledge is required. This is a revision of a course given last year. Mon., May 23, 9-4; Hilton Atlanta; fee: advance $160, on site $185; spaces available: 175. A similar course on this topic will be offered on Sat, May 21, 9-4. See Course 7 for details.

COURSE 48: DAVANLOO'S INTENSIVE SHORT-TERM DYNAMIC PSYCHOTHERAPY IN CLINICAL PRACTICE

Director: James Q. Schubmehl, M.D. Faculty: Alan R. Beeber, M.D., Tewfik Said, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) acquire a vivid sense of the forces underlying human psychopathology and a view of crucial elements of the healing process and (2) describe main elements of Davanloo's technique and find many aspects of the presentation useful to his/her own clinical practice. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 23, 9-4; Hilton Atlanta; fee: advance $160, on site $185; spaces available: 50

COURSE 49: THE ADVANCED PRACTICE OF PSYCHOTHERAPY

Director: T. Byram Karasu, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) identify deficit and conflict-oriented diagnoses as universal pathology; (2) differentially use specific and generic therapeutic techniques; (3) transcend paradigms of relationships and schools of psychotherapy; and (4) formulate a philosophical perspective that can further professional formation and personal growth. Course Level: This is an advanced course. Participants must be familiar with the basic concepts of psychotherapy. This is a repeat of a course given last year. Mon., May 23, 1-5; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 40

COURSE 50: ASSESSMENT AND TREATMENT OF DRUG-INDUCED MOVEMENT DISORDERS

Director: Anton J.M. Loonen, M.D. Educational Objective: At the conclusion of this course, the participant should be able to judge the adequacy of the instruments used or to be used in clinical trials. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon, May 23, 1-5; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 25

COURSE 51: COGNITIVE THERAPY FOR SEVERE MENTAL DISORDERS

Director: Jesse H. Wright, M.D. Faculty: Michael E. Thase, M.D., Monica A. Basco, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) utilize cognitive therapy (CT) interventions for severe depression; (2) apply CT techniques to symptoms of severe depression, psychosis, and bipolar disorder; and (3) address treatment adherence problems. Course Level: This is an intermediate course. Participants should be familiar with principles and practices of cognitive-behavioral therapy. This is a revision of a course given last year. Mon., May 23, 1-5; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 50

COURSE 52: PSYCHIATRY AND THE INTERNET

Director: Robert S. Kennedy, M.A. Faculty: Thomas A.M. Kramer, M.D., Carlyle H. Chan, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) recognize the power of the Internet as a resource for the practice of psychiatry; (2) review the technology of the Internet and how it impacts the clinician and educator of today; and (3) discuss current and future applications of the Internet for the practice of medicine and psychiatry. Course Level: This is a basic course. No prior experience or knowledge is required. This is a revision of a course given last year. Mon., May 23, 1-5; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 25

COURSE 53: ECT PRACTICE UPDATE

Director: Charles H. Kellner, M.D. Faculty: Richard L. Jaffe, M.D., W. Vaughn McCall, M.S., Richard D. Weiner, M.D. Educational Objective: At the conclusion of this course, the participant should be able to understand and be familiar with the most current ECT techniques. Course Level: This is an intermediate course. Participants should refer to the APA Practice Guideline for the Treatment of Patients With Major Depression. Participants should have knowledge of which patients should be referred for ECT and have basic knowledge of ECT procedure. This is a revision of a course given last year. Mon., May 23, 1-5; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 90

COURSE 54: OVERVIEW AND UPDATE OF SLEEP DISORDERS MEDICINE

Director: Karl Doghramji, M.D. Faculty: John W. Winkelman, M.D., Thomas D. Hurwitz, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) understand polysomnographic techniques and central mechanisms regulating sleep and wakefulness; (2) appreciate the prevalence and impact of sleep disorders; and (3) identify the major sleep disorders, their evaluation, and treatments. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Mon., May 23, 1-5; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 100. A similar course on this topic will be offered on Tue., May 24, 8-12. See Course 63 for details.

COURSE 55: TREATING MEDICAL STUDENTS AND PHYSICIANS

Co-Directors: Michael F. Myers, M.D., Leah J. Dickstein, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) understand the role of stigma and other obstacles to care when treating medical students and physicians; (2) employ advocacy strategies on behalf of their patients; (3) appreciate the challenges when treating physicians with depression; and (4) identify transference and countertransference dynamics. Course Level: This is an intermediate course. Participants should have some experience in treating medical students and physicians. This is a repeat of a course given last year. Mon., May 23, 1-5; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 50

COURSE 56: CHILD MURDER BY PARENTS

Director: Phillip J. Resnick, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) understand the reasons that parents kill their children and (2) prevent tragedies such as the Andrea Yates case. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 23, 1-5; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 50. A similar course on this topic will be offered on Sat., May 21, 1-5. See Course 8 for details.

COURSE 57: DRUG TREATMENT OF SCHIZOPHRENIA

Director: Philip G. Janicak, M.D. Faculty: Morris B. Goldman, M.D., Stephen R. Marder, M.D., Rajiv Tandon, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) describe the clinically relevant aspects of pharmacology of first- and second-generation antipsychotic drugs and (2) understand their uses for acute and chronic schizophrenia. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Mon., May 23, 1-5; Hilton Atlanta; fee: advance $100, on site $130; spaces available: 100